USD 0.68
(1.49%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -22.93 Million USD | 69.04% |
2022 | -74.08 Million USD | -216.67% |
2021 | -23.39 Million USD | -285.64% |
2020 | 12.6 Million USD | 127.74% |
2019 | -45.42 Million USD | -10924.64% |
2018 | -412.07 Thousand USD | 76.3% |
2017 | -1.73 Million USD | 48.2% |
2016 | -3.35 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -996.5 Thousand USD | 93.72% |
2024 Q2 | -4.01 Million USD | -302.51% |
2024 Q3 | 459.73 Thousand USD | 111.46% |
2023 Q4 | -15.87 Million USD | -796.68% |
2023 Q3 | -1.77 Million USD | -102.92% |
2023 FY | -22.93 Million USD | 69.04% |
2023 Q1 | -4.95 Million USD | 68.29% |
2023 Q2 | 60.55 Million USD | 1321.78% |
2022 Q2 | -4.3 Million USD | 77.54% |
2022 Q4 | -15.63 Million USD | 52.1% |
2022 FY | -74.08 Million USD | -216.67% |
2022 Q1 | -19.16 Million USD | -533.19% |
2022 Q3 | -32.63 Million USD | -658.23% |
2021 Q1 | -9.39 Million USD | -50.12% |
2021 Q2 | -12.51 Million USD | -33.15% |
2021 FY | -23.39 Million USD | -285.64% |
2021 Q4 | -3.02 Million USD | -296.85% |
2021 Q3 | 1.53 Million USD | 112.29% |
2020 Q2 | 14.78 Million USD | 14.93% |
2020 Q1 | 12.86 Million USD | 15.13% |
2020 FY | 12.6 Million USD | 127.74% |
2020 Q4 | -6.25 Million USD | 30.09% |
2020 Q3 | -8.95 Million USD | -160.56% |
2019 Q1 | -584.38 Thousand USD | 34.31% |
2019 FY | -45.42 Million USD | -10924.64% |
2019 Q4 | 11.17 Million USD | 140.33% |
2019 Q3 | -27.69 Million USD | 12.87% |
2019 Q2 | -31.79 Million USD | -5340.2% |
2018 Q1 | -1.13 Million USD | -234.86% |
2018 Q2 | 1.4 Million USD | 223.96% |
2018 Q3 | 206.07 Thousand USD | -85.33% |
2018 Q4 | -889.61 Thousand USD | -531.7% |
2018 FY | -412.07 Thousand USD | 76.3% |
2017 FY | -1.73 Million USD | 48.2% |
2017 Q1 | -634.47 Thousand USD | 38.51% |
2017 Q2 | -555.23 Thousand USD | 12.49% |
2017 Q3 | -210.69 Thousand USD | 62.05% |
2017 Q4 | -338.32 Thousand USD | -60.58% |
2016 Q3 | -1.2 Million USD | 0.0% |
2016 Q4 | -1.03 Million USD | 14.47% |
2016 FY | -3.35 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
China Pharma Holdings, Inc. | -3.07 Million USD | -645.033% |
cbdMD, Inc. | -22.93 Million USD | -0.0% |
Zomedica Corp. | -34.52 Million USD | 33.568% |